The incidence of comorbid diseases in patients diagnosed with fibromyalgia

Harun Düğeroğlu

doi:10.21601/ortadogutipdergisi.448880

ORTADOĞU TIP DERGİSİ - ORTADOGU MEDICAL JOURNAL

The incidence of comorbid diseases in patients diagnosed with fibromyalgia

Fibromiyalji tanısı konulan hastalarda komorbid hastalıkların görülme sıklığı

Harun Düğeroğlu ¹ ^*

More Detail

Ortadogu Tıp Derg, Volume 11, Issue 2, pp. 131-135

https://doi.org/10.21601/ortadogutipdergisi.448880

OPEN ACCESS

Download Full Text (PDF)

Abstract

Aim: The aim of the study was to determine the frequency of comorbid diseases in patients diagnosed with fibromyalgia by the Physical Therapy Clinic.
Material and Method: Data of 674 patients diagnosed with fibromyalgia between January 2013 and May 2018 were retrospectively reviewed. Comorbid disease data of patients diagnosed with fibromyalgia were analyzed statistically.
Results: 208 (30.8%) of the 674 patients were male and 466 (69.2%) were female. The mean age of the patients was 49.2±10.4 years in males and 50.4±12.7 years in females. There were at least one comorbid disease in 548 patients (81.3%) and no comorbid disease in 126 (18.6%) patients. The most common comorbid diseases were cardiovascular diseases in 224 (40.8%) patients and endocrine diseases in 187 (34.1%) patients.
Conclusion: Fibromyalgia is an increasingly prevalent disease in recent years. Close monitoring of comorbid disease states of patients diagnosed with fibromyalgia will be useful in the treatment of fibromyalgia.

Keywords: Comorbidity, fibromyalgia, incidence, chronic diseases

Öz

Amaç: Çalışmanın amacı, Fizik Tedavi kliniği tarafından fibromiyalji tanısı konulan hastalarda komorbid hastalıkların sıklığını belirlemeyi amaçladık.
Gereç ve Yöntem: Çalışmaya Ocak 2013 - Mayıs 2018 tarihleri arasında fibromiyalji tanısı konulan 674 hastanın verileri retrospektif olarak incelenmiştir. Fibromiyalji tanısı konulan hastaların komorbid hastalık verileri istatistiksel olarak analiz edildi.
Bulgular: Çalışmaya alınan 674 hastanın 208 (%30,8)’i erkek, 466 (%69,2)’ı kadın hastalardı. Hastaların yaş ortalaması, erkeklerde 49,2±10,4 yıl, kadınlarda 50,4±12,7 yıldı. Hastaların 548 (%81,3)’inde en az bir komorbid hastalık varken, 126 (%18,6) hastada herhangi bir komorbid hastalık yoktu. En sık görülen komorbid hastalık 224 (%40,8) hasta ile kardiyovasküler hastalıklar, ikinci sırada 187 (%34,1) hasta ile endokrin hastalıklar yer almaktadır.
Sonuç: Fibromiyalji, son yıllarda sıklığı giderek artan bir hastalıktır. Fibromiyalji tanısı konulan hastaların, komorbid hastalık durumlarının yakından takip edilmesi, fibromiyaljinin tedavisinde yararlı olacaktır.

Keywords: Komorbidite, fibromiyalji, insidans, kronik hastalıklar

References

Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disorders 2007; 8:27.
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19-28.
Forseth KO, Gran JT, Husby G. A population study of the incidence of fibromyalgia among women aged 26-55 years. Br J Rheumatol 1997; 36: 1318-23.
White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 1999; 26: 1577-85.
Gur A, Cevik R, Nas K, Sarac AJ, Ozen Ş. Quality of life in young fibromyalgia patients and effect of deppression. Aplar J Rheumatol 2006; 9: 70-8.
Clauw DJ. Fibromyalgia: An overview. Am J Med 2009; 122: 3-13.
Choy EH, Mease PJ. Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials). Rheum Dis Clin North Am 2009; 35: 329-37.
Soran N, Altindag Ö, Demirkol A, ve ark. Depression level and relation with clinical parameters in fibromyalgia syndrome. Rheum 2008; 23: 1-4.
Wolfe F, Hassett AL, Walitt B, Michaud K. Mortality in fibromyalgia: A study of 8,186 patients over thirty?five years. Arthritis Care Res 2011; 63: 94-101.
Wolfe F, Clauw DJ, Fitzcharles MA, ve ark. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010; 62: 600-10.
Wolfe F, Smythe HA, Yunus MB, ve ark. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33: 160-72.
İnanıcı F. Fibromiyalji ve Miyofasiyal Ağrı Sendromları. Türkiye Klinikleri J Med Sci 2005; 1: 11-8.
Al-Allaf A, Mole P, Paterson C, Pullar T. Bone health in patients with fibromyalgia. Rheumatology (Oxford). 2003; 42: 1202-06.
Baysal Ö, Altay Z, Öner T, Dilek Y, Ünal S, Kaya B. Fibromiyaljili hastalarda venlafaksin ve amitriptilinin karşılaştırılması. Hipokrat Lokomotor 2005; 6:36.
Karakoç M, Nas K, Çevik R, Erdoğan F, Saraç AY, Coşut S. Fibromiyaljili Hastalarda Amitriptilin ve Lazer Tedavilerinin Etkinliklerinin Karşılaştırılması. Türkiye Fiziksel Tıp ve Rehabilitasyon Derg 2001; 3:47.
Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F. The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PloS One 2015 https://doi.org/10.1371/journal.pone.0138024
Gerwin RD. Myofascial and visceral pain syndromes: visceralsomatic pain representations. J Musculoskeletal Pain 2002; 10: 165-75.
Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992; 92: 363-7.
Bilgici A, Akdeniz O, Güz H, Ulusoy H. The Role of Depression and Social Adjustment in Fibromyalgia Syndrome. Turk J Phys Med Rehab 2005; 5: 98-102.
Hayta E, Doğan ÖT, Doğan SC, ve ark. Clinical features of 100 female patients with fibromyalgia. Cumhuriyet Med J 2010; 32: 74-9.
Giesecke T, Williams DA, Harris RE, ve ark. Subgrouping of fibromyalgia patients on the basis of pressurepain thresholds and psychological factors. Arthritis Rheumatism 2003; 48: 2916-22.
Fred-Jimenez RM, Arroyo-Avila M, Mayor AM, Rios G, Vila LM. Clinical Manifestations Associated with Overweight/ Obesity in Puerto Ricans with Fibromyalgia Syndrome. J Obes 2016; 2016:1379289.
Jackson JL, Mally PG, Tomkins G, ve ark. Treatment of functional gastrointestinal disorders with antidepresant medications: a metaanalysis. Am J Med 2000; 108: 65-72.
Korszun A, Young EA, Engleberg NC, ve ark. Follicular phase hypothalamic-pituitary-gonadal axis function in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 2000; 27: 1526-30.
Okifuji A, Turk DC. Sex hormones and pain in regularly menstruating women with fibromyalgia syndrome. J Pain 2006; 7: 851-9.
Clauw DJ, Katz P. The overlap between fibromyalgia and inflammatory Rheum disease: when and why does it occur? J Clin Rheumatol 1995;1:335-42.
Arnold LM, Clauw DJ, McCarberg BH. Fibro Collaborative. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 2011; 86: 457-64.

Citation

Düğeroğlu H. The incidence of comorbid diseases in patients diagnosed with fibromyalgia. Ortadogu Tıp Derg. 2019;11(2):131-5. https://doi.org/10.21601/ortadogutipdergisi.448880

Düğeroğlu, H. (2019). The incidence of comorbid diseases in patients diagnosed with fibromyalgia. Ortadoğu Tıp Dergisi, 11(2), 131-135. https://doi.org/10.21601/ortadogutipdergisi.448880

Düğeroğlu, H. (2019). The incidence of comorbid diseases in patients diagnosed with fibromyalgia. Ortadoğu Tıp Dergisi, 11(2), pp. 131-135. https://doi.org/10.21601/ortadogutipdergisi.448880

Düğeroğlu H. The incidence of comorbid diseases in patients diagnosed with fibromyalgia. Ortadogu Tıp Derg. 2019;11(2), 131-135. https://doi.org/10.21601/ortadogutipdergisi.448880

Düğeroğlu, Harun. "The incidence of comorbid diseases in patients diagnosed with fibromyalgia". Ortadoğu Tıp Dergisi 2019 11 no. 2 (2019): 131-135. https://doi.org/10.21601/ortadogutipdergisi.448880

Düğeroğlu, Harun "The incidence of comorbid diseases in patients diagnosed with fibromyalgia". Ortadoğu Tıp Dergisi, vol. 11, no. 2, 2019, pp. 131-135. https://doi.org/10.21601/ortadogutipdergisi.448880